Irbesartan Tablet
Product Images NDC 71205-452

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 71205-452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Irbesartanfigure3.jpg (Irbesartanfigure3)

The text describes a table showing the cumulative event rate (percentage) for two groups named "Oaran v Pacebo" and "Einan v Ariadipne" over a period of 60 months. The first group has a rate of 0.50% while the second has a rate of 0.77% at the beginning of the observation period, and then the rates increase progressively over time. The table seems to represent an analysis in the medical field, but without more context, it is not possible to know the exact nature of the comparison between the two groups.*

FDA Label Image

Image2 (Camber1)

FDA Label Image

Image1 (Image1)

FDA Label Image

Image2 (Image2)

FDA Label Image

71205-452-30 (Irbetab150mg30scount)

This is a medication called Irbesartan 150mg, packaged by Proficient Rx LP. It comes in a pack of 30 tablets, each containing 150 mg of Irbesartan USP. The tablets are white and biconvex with '159' and 'H" debossed on each side. The lot number is '00000' with an expiration date of '00/00/00'. The manufacturer is Hetero Labs Limited in India. The medication should be stored between 20°C-25°C (68°F-77°F) and kept out of children's reach.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.